Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hevilo Life Sciences is a biotechnology company specializing in regenerative medicine and cellular therapies aimed at extending human healthspan. The company provides advanced treatments utilizing mesenchymal stem cells and exosomes to address chronic conditions such as autoimmune disorders, orthopedic injuries, and age-related degeneration. Operating primarily through its clinical facilities, Hevilo focuses on the application of cutting-edge biologics to promote tissue repair and systemic rejuvenation. Their approach integrates personalized medicine with high-potency cellular products to optimize patient outcomes in longevity and wellness. Hevilo's services are designed to bridge the gap between laboratory research and clinical application in the field of regenerative science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hevilo Life Sciences.